ketoconazole has been researched along with Chronic Kidney Diseases in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The calcimimetic cinacalcet hydrochloride (cinacalcet) is used for treatment of patients with chronic kidney disease with secondary hyperparathyroidism, a population that commonly receives multiple concurrent medications." | 5.12 | Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole. ( Harris, RZ; Padhi, D; Salfi, M; Sullivan, JT, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagamani, S | 1 |
| Muthusamy, K | 1 |
| Harris, RZ | 1 |
| Salfi, M | 1 |
| Sullivan, JT | 1 |
| Padhi, D | 1 |
1 trial available for ketoconazole and Chronic Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole.
Topics: Administration, Oral; Adult; Analysis of Variance; Antifungal Agents; Area Under Curve; Calcium; Cin | 2007 |
1 other study available for ketoconazole and Chronic Kidney Diseases
| Article | Year |
|---|---|
A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.
Topics: Humans; Hydrogen Bonding; Ketoconazole; Ligands; Molecular Docking Simulation; Molecular Dynamics Si | 2018 |